LEVEL FOUR ADVISORY SERVICES, LLC
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 1696715
DALLAS, TX
Position in JAZZ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$840,985
+$184,793 QoQ
Shares Held
3,490
+0.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#342
of 646 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $9,160,165 across 9 Biotechnology names. JAZZ ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,034 | $4,984,188 | |
| 2 | GMAB |
Genmab A/S
|
58,000 | $1,593,260 | |
| 3 | ARGX |
Argenx SE
|
1,148 | $1,065,079 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
3,490 | $840,985 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
5,506 | $312,795 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
396 | $246,921 | |
| 7 | MNKD |
Mannkind Corp
|
21,338 | $90,899 | |
| 8 | OCGN |
Ocugen, Inc.
|
17,000 | $26,010 |
All Filings in JAZZ
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $840,985 | 3,490 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $656,192 | 3,471 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $588,880 | 3,464 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $456,028 | 3,460 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $367,175 | 3,460 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||